Active Pharmaceutical Ingredientia
Progestogen et estrogen | |||
Product Name | Specificatio | Probatus | Cas No. |
Progesterone | CP / EP / USP / JP | CEP / EU-GMP / FDA | 57-83-0 |
Pregnenolone | In-domo |
Kosher | 145-13-1 |
Medroxyprogesterone ACETATE | CP / EP / USP / JP | Dmf / GMP | 71-58-9 |
MESTERROL acetate | CP / EP / USP | Dmf in processususus | 595-33-5 |
Mifepristone | CP / IP | Dmf / GMP | 84371-65-3 |
Cyproterone acetate | CP / EP / IP / KP | CEP / TGA / EU-GMP | 427-51-0 |
Levonorgestrel | CP / EP / USP / IP | CEP / GMP | 797-63-7 |
Norethisterone |
CP / EP / USP / JP |
Dmf in processususus |
68-22-4 |
Norethisterone acetate |
EP / USP |
Dmf in processususus |
51-98-9 |
Norethisterone Enanthate |
In-domo |
Sub R & D |
3836-23-5 |
Dripirenone | EP / USP | Dmf | 67392-87-4 |
Gestodene | CP / Album | Dmf / GMP | 60282-87-3 |
Estradiol | CP / EP / USP / KP | Dmf / GMP / WC | 35380-71-3 |
Estriol | CP / EP / USP | Sub R & D | 50-27- I |
Ethinyl estradiol | CP / EP / USP | Gmp | 57-63-6 |
Estradiol Valerate | CP / EP / USP / KP | Dmf | 979-32-8 |
Estradiol cypionate |
Usp | Dmf in processususus |
313-06-4 |
Tubolone | CP / Album | Dmf / GMP | 5630-53-5 |
Dienogest | Map | CEP / GMP | 65928-58-7 |
Fullevestrant | EP / USP | Sub R & D | 129453-61-8 |
Exemestane | CP / EP / USP | Sub R & D | 107868-30-4 |
Androgen | |||
Product Name | Specificatio | Probatus | Cas No. |
Finasteride | CP / EP / USP | CEP / FDA / PMDA / GMP | 98319-26-7 |
PRAESTITUTUM | EP / USP | CEP / FDA | 164656-23-9 |
Abiratone acetate | CP / USP | Dmf / WC | 154229-18-2 |
Darolutami |
In-domo |
Sub R & D |
1297538-32-9 |
Testosterone | CP / EP / USP | CEP / WC / FDA | 58-22-0 |
Testosterone undecanoate | CP | Dmf / WC | 5949-44-0 |
Testosterone cypionate | Usp | Sub R & D | 58-20-8 |
Testosterone enanthate |
USP / JP | Sub R & D |
315-37-7 |
Testosterone propionate |
CP / EP / USP / JP |
Sub R & D |
57-85-2 |
DHEA (in pracers) | FP /In-domo | Dmf / WC / Kosher | 53-43-0 |
Clascoterone | In-domo | Dmf in processususus | 19608-29-8 |
Cortical hormone | |||
Product Name | Specificatio | Probatus | Cas No. |
Budesonide | CP / EP / USP / JP | CEP / FDA / GMP | 51333-22-3 |
DESON | CP / USP | Dmf / GMP | 638-94-8 |
Eplerenone | Map | CEP in processusus | 107724-20-9 |
Methylprednisolone | CP / EP / USP / JP | Dmf / GMP | 83-43-2 |
Methylprednisolone Hemisuccinate | CP / EP / USP | Dmf / GMP | 2921-57-5 |
Fluticasone propionate | CP / EP / USP | Dmf | 80474- 14-2 |
Fluticasone ira | CP / Album | Dmf in processususus | 397864-44-7 |
Mometasone furoate |
CP / EP / USP |
Dmf in processususus |
Anhydrous (83919-23-7) Monohydrate (141646-00-6) |
Deflazacort |
In-domo |
Sub R & D |
14484-47-0 |
Alii | |||
Product Name | Specificatio | Probatus | Cas No. |
Oxcarbazepine | CP / EP / USP / IP | CEP / FDA / GMP | 28721-07-5 |
ESICARBAZEPAZIPAE ACETATE | CP / USP | Dmf | 236395- 14-5 |
Ganciclovir | CP / EP / USP | Dmf / GMP | 82410-32-0 |
VALCANCICLOVIR Hydrochloride | USP / Album | CEP in processus | 175865-59-5 |
Oseltamivir phosphate | CP / EP / USP | Dmf | 204255- 11-8 |
Baloxavir Marboxil | In-domo | Sub R & D | 1985606-14-1 |
Revefenacin | In-domo | Dmf | 864750-70-9 |
Mirabegron | CP / Album | Dmf | 223673-61-8 |
Vibegron |
In-domo |
Sub R & D |
1190389-15-1 |
Escitalopram oxalate | CP / EP / USP | Dmf in processusus | 219861-08-2 |
Citalopram hydrobromide |
CP / EP / USP |
Dmf in processususus |
59729-32-7 |
Cariprazine Hydrochloride | In-domo | Dmf | 1083076-69-0 |
LASMIDITAN | In-domo | Dmf | 439239-92-6 |
Luliconazole | In-domo | Dmf | 187164-19-8 |
Apalutami | In-domo | Dmf | 956104-40-8 |
Tadalafil | CP / EP / USP | Sub R & D | 171596-29-5 |
Relugolix | In-domo | Dmf in processusus | 737789-87-6 |
Phosphate Ruxolitinib |
In-domo |
Dmf in processususus |
1092939-17-7 |
Abemaciclib |
In-domo |
Sub R & D |
1231929-97-7 |
Phloroglucinol | CP / Album | Dmf | 108-73-6 |
1,3,5, trimethoxybenzene |
CP / in-Domus |
Gmp |
621-23-8 |
Ursodeoxycholic acidum | EP / USP / JP | Sub R & D | 128-13-2 |
Tauroursodeoloxycholic acidum |
In-domo |
Sub R & D |
14605-22-2 |
Cholesterol |
CP / EP / USP / JP |
Sub R & D |
57-88-5 |
Omega-III-acidum ethyl aether XC |
EP / USP |
Dmf in processususus |
- |
Medium-torquem triglycerides |
CP / USP / Album |
Dmf |
- |
Benzalkonium chloride |
USP / EP / JP |
CEP in processusus |
8001-54-5 |
Oleum (quia iniectio) |
CP / USP / EP / JP |
Dmf in processususus |
8001-25-0 |
Ovum phospholipids (quia iniectio) |
CP / USP / Album |
Dmf |
93685-90-6 |
Snack |
In-domo |
Dmf in processususus |
203787-91-1 |
Testosterone CP, EP et USP specificationes habet. CEP, DMF, WC, FDA in promptu sunt.
Testosterone undecanoatus CP specificationem habet. TP in promptu et DMF sub interpositione.
Testosteronus cypionatus USP specificationem habet.TP praesto et DMF sub interpositione.
DHEA (Prasterone) habet FP et In-domus specification.DMF et WC in promptu.
Gestodenus habet CP et EP specificationem. DMF, GMP available.
Ethinyl Estradiol habet USP, EP et CP specifications.DMF et GMP in promptu.